Tuberous Sclerosis Alliance Lauds FDA Approval of Epidiolex® to Treat Seizures in People with Tuberous Sclerosis Complex
Silver Spring, MD – Today, the Tuberous Sclerosis Alliance (TS Alliance) lauds the U.S. Food and Drug Administration’s (FDA’s) approval of Epidiolex® oral solution to treat seizures in people one year of age and older who have tuberous sclerosis complex (TSC). Affecting approximately…